State of play on EU medtech regulatory reforms: a big, unpalatable stew
This article was originally published in SRA
Executive Summary
The medtech sector in the EU has arguably witnessed more pivotal documents being issued over the last few weeks than in the region’s 25-year history of medical device and in vitro diagnostic regulation1.